This content is machine translated SARS-CoV-2 Swissmedic approval of a second COVID-19 vaccine Moderna’s vaccine, approved by Swissmedic on January 12, 2021, is an mRNA vaccine, as was Pfizer/BioNTech’s candidate BNT162, approved in December. The Swiss federal government has secured 7.5 million cans.…
View Post 1 min This content is machine translated Multiple sclerosis Cladribine tablets show rapid onset of action Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system and is the most common non-traumatic neurological disease leading to severe impairment in young adults.
View Post 2 min This content is machine translated Migraine prophylaxis Erenumab shows good results compared to topiramate Migraine prophylaxis with CGRP antibodies is characterized above all by a rapid onset of action and good tolerability. A phase IV comparative study evaluated erenumab against the anticonvulsant topiramate in…
View Post 3 min This content is machine translated Acute bacterial rhinosinusitis Quickly and gently unclog sinuses Sinusitis is one of the most common colds during the cold season. It is estimated that about one in seven cases of rhinitis results in acute rhinosinusitis. In most cases,…
View Post 2 min This content is machine translated Hypertension Detect changes already in childhood and initiate prevention High blood pressure is the cause of a number of sequelae, such as microvascular retinal changes. Hypertension can already begin in childhood – in most cases undetected. This is to…
View Post 2 min This content is machine translated Paroxymal Nocturnal Hemoglobinuria (PNH) Ravulizumab now reimbursable The first approved long-acting complement inhibitor for patients with PNH, ravulizumab, has been approved for nationwide reimbursement by the federal health department. This gives adult PNH patients in Switzerland access…
View Post 1 min This content is machine translated BRCA-mutated advanced ovarian cancer. PARP inhibitor shows long-term benefit in terms of PFS Ovarian cancer is the eighth leading cause of death among women with cancer worldwide. In Switzerland, approximately 620 patients are newly diagnosed with ovarian cancer each year. Approximately 22% of…
View Post 2 min This content is machine translated Migraine prevention Erenumab effective and safe in the long term in clinical practice Recent trial data strengthen the role of erenumab as a preventive migraine treatment. They confirm the real and long-term benefits of the CGRP inhibitor in terms of safety and efficacy…
View Post 3 min This content is machine translated Non-small cell lung cancer and other solid tumors In the pipeline: KRAS G12C inhibitor Sotorasib The KRAS gene is one of the most frequently mutated oncogenes in human cancers and thus represents a promising target in the therapy of diverse solid tumors. Sotorasib is currently…
View Post 3 min This content is machine translated Treatment resistant depression Esketamine nasal spray: new mechanism of action fuels hope When patients with moderate to severe depression do not respond to two different antidepressants, further therapeutic options have been very limited. With approval of the new esketamine nasal spray, there…
View Post 1 min This content is machine translated Corona pandemic EMA reviews first COVID-19 vaccine candidate AZD1222, a vaccine developed by AstraZeneca in collaboration with the University of Oxford, is under rolling review by the Committee for Medicinal Products for Human Use of the European Medicines…
